Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-08

Clinical Trial Update: Dextromethorphan for Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating dextromethorphan for diabetic macular edema completed with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-06-08